Stock 002773 CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Chengdu Kanghong Pharmaceutical Group Co., Ltd

Equities

002773

CNE1000020C4

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
22.35 CNY +0.13% Intraday chart for Chengdu Kanghong Pharmaceutical Group Co., Ltd -1.15% +21.20%
May. 22 Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 May 2024 CI
Apr. 29 Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 32,296 44,373 18,711 14,426 16,955 20,550 -
Enterprise Value (EV) 1 30,012 41,045 18,711 14,426 16,955 20,550 20,550
P/E ratio 45.1 x -157 x 44.2 x 16 x 16.2 x 16.9 x 14.1 x
Yield 0.76% 0.21% 0.49% - 2.06% - -
Capitalization / Revenue 9.91 x 13.5 x 5.19 x - 4.28 x 4.78 x 4.15 x
EV / Revenue 9.91 x 13.5 x 5.19 x - 4.28 x 4.78 x 4.15 x
EV / EBITDA 35.2 x -114 x 37.1 x - 11.4 x 13.1 x 11.1 x
EV / FCF -214,263,978 x -129,098,563 x - - - - -
FCF Yield -0% -0% - - - - -
Price to Book 7.01 x 7.71 x 3.07 x - 2.17 x 2.29 x 1.97 x
Nbr of stocks (in thousands) 873,573 921,555 919,464 919,464 919,464 919,464 -
Reference price 2 36.97 48.15 20.35 15.69 18.44 22.35 22.35
Announcement Date 2/27/20 2/26/21 4/29/22 4/27/23 4/24/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 3,257 3,295 3,605 - 3,957 4,302 4,946
EBITDA 1 916.4 -390.8 505 - 1,486 1,573 1,859
EBIT 1 820.8 -512.3 355.2 - 1,261 1,443 1,735
Operating Margin 25.2% -15.55% 9.85% - 31.87% 33.54% 35.08%
Earnings before Tax (EBT) 1 835.2 -519.5 393.4 - 1,234 1,443 1,735
Net income 1 718.2 -269.9 421.1 896.7 1,045 1,215 1,461
Net margin 22.05% -8.19% 11.68% - 26.4% 28.24% 29.54%
EPS 2 0.8200 -0.3074 0.4600 0.9800 1.140 1.320 1.590
Free Cash Flow -150.7 -343.7 - - - - -
FCF margin -4.63% -10.43% - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 0.2800 0.1000 0.1000 - 0.3800 - -
Announcement Date 2/27/20 2/26/21 4/29/22 4/27/23 4/24/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position 2,284 3,328 - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow -151 -344 - - - - -
ROE (net income / shareholders' equity) 16.7% -5.84% 7.12% - 14.2% 13.5% 14%
ROA (Net income/ Total Assets) 13% -4.21% 6.05% - - 12.2% 12.8%
Assets 1 5,511 6,414 6,956 - - 9,959 11,414
Book Value Per Share 2 5.280 6.250 6.620 - 8.490 9.770 11.40
Cash Flow per Share 2 0.9300 0.3000 0.5400 - 1.330 1.760 1.350
Capex 1 963 617 569 - 139 130 130
Capex / Sales 29.56% 18.72% 15.79% - 3.5% 3.02% 2.63%
Announcement Date 2/27/20 2/26/21 4/29/22 4/27/23 4/24/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Chengdu Kanghong Pharmaceutical Group Co., Ltd

Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
22.35
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD Stock Chengdu Kanghong Pharmaceutical Group Co., Ltd
+21.20% 2.83B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 734B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 591B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 315B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 276B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 238B
NOVARTIS AG Stock Novartis AG
+9.78% 206B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 204B
AMGEN INC. Stock Amgen Inc.
+6.17% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002773 Stock
  4. Financials Chengdu Kanghong Pharmaceutical Group Co., Ltd